Pfizer/BioNTech COVID-19 Boosters For Seniors, Certain Vulnerable Adults Coming Soon - CDC Panel Recommends - Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX)

The Centers for Disease Control and Prevention (CDC) backed a booster shot of Pfizer Inc PFE and BioNTech SE BNTX COVID-19 vaccine for Americans aged 65 and older and adults with an underlying medical condition.
It also said that residents of nursing homes and other long-term-care facilities should also get the extra shots.
But the panel disagreed about giving the booster to people in high-risk jobs, such as teachers, and risky living conditions.
The CDC recommendation follows FDA authorization and clears the way for a booster rollout to begin soon for people who had their second dose of the Pfizer shot at least six months ago.
Related Content: Pfizer COVID-19 Vaccine Booster Shot Approved By FDA For High-Risk Individuals, People 65 And Up.
CDC Director Rochelle Walensky said her agency had to make recommendations based on complex, often imperfect data.
The CDC said that group is currently about 26 million people, including 13 million age 65 or older.
Read Next: EMA To Decide On Pfizer/BioNTech COVID-19 Booster Next Month.
Price Action: PFE stock is down 0.16% at $44.12, while BNTX stock is down 0.25% at $352.10 during the premarket session on the last check Friday.
Photo by x3 from Pixabay

Pfizer/BioNTech COVID-19 Boosters For Seniors, Certain Vulnerable Adults Coming Soon - CDC Panel Recommends